– Les extractions de données cliniques issues du programme TIGIT attendues en 2024, dont deux essais de Phase II évaluant belrestotug + dostarlimab dans le CPNPC en 1re ligne et le CETC en 1re ligne
- The York Water Company Reports Three Months Earnings - May 6, 2025
- WellSpan boosts access to foot and ankle care with the addition of Martin Foot and Ankle - May 6, 2025
- SEALSQ’s Advanced Cybersecurity Solutions for Drone and Satellite Telecommunications, Position It as a Technology Leader in Key Sectors Including Defense, Smart Farming and Logistics - May 6, 2025